U.S. Senators To Introduce Bill Aimed At Speeding Development Of Ebola Drugs

News outlets report that leaders of the U.S. Senate Health Committee are planning on introducing a bill that would offer incentives for companies to develop Ebola treatments and vaccines.

Chattanooga Times Free Press: Lamar Alexander to introduce bill to speed development of Ebola treatment
“Republican U.S. Sen. Lamar Alexander will introduce a bill with Iowa Sen. Tom Harkin to help speed the development of Ebola treatments and vaccines. The bill is designed to add Ebola to FDA’s priority review ‘voucher’ program, a program at the Food and Drug Administration designed to incentivize the development of new drugs for neglected tropical diseases…” (10/28).

The Hill: Senators plan bill to speed up approval of Ebola drugs
“Leaders of the Senate Health Committee are planning to introduce a bill that would fast-track the creation of Ebola treatments by offering incentives to drug companies…” (Ferris, 10/28).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.